| Bioactivity | Lotiglipron (PF-07081532) is an orally active GLP-1R agonist. Lotiglipron reduces glucose and body weight, and can be used for research of Type 2 diabetes mellitus (T2DM)[1]. |
| Name | Lotiglipron |
| CAS | 2401892-75-7 |
| Formula | C31H31ClN4O5 |
| Molar Mass | 575.05 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Buckeridge C, et al. Once-daily oral small molecule GLP-1R agonist PF-07081532 reduces glucose and body weight within 4-6 weeks in adults with type 2 diabetes and non-diabetic adults with obesity. Hybrid 58th EASD Annual Meeting; Sept 19–23, 2022 (abstr 114). |
Lotiglipron
CAS: 2401892-75-7 F: C31H31ClN4O5 W: 575.05
Lotiglipron (PF-07081532) is an orally active GLP-1R agonist. Lotiglipron reduces glucose and body weight, and can be us
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.